Donald F. Klein

Q: What Schools Are Affiliated With Donald F. Klein

Donald F. Klein is affiliated with the following schools: Columbia University, New York University, Colby College

Donald F. Klein's AcademicInfluence.com Rankings

Donald F. Klein

Biology

#2627

World Rank

#4142

Historical Rank

#1159

USA Rank

biology Degrees

Download Badge

Biology

Why Is Donald F. Klein Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Donald Franklin Klein was an American psychiatrist known for his work on anxiety disorders. From 1976 until his emeritate in 2006, he was professor of psychiatry at Columbia University in New York and medical director of the New York State Psychiatric Institute.

(See a Problem?)

Donald F. Klein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cognitive therapy. (1994) (1347)
The oscillating brain: Complex and reliable (2010) (1127)
False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. (1993) (1043)
Reliable intrinsic connectivity networks: Test–retest evaluation using ICA and dual regression approach (2010) (725)
Social phobia. Review of a neglected anxiety disorder. (1985) (564)
Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. (1986) (561)
Endogenomorphic depression. A conceptual and terminological revision. (1974) (556)
Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. (2000) (503)
Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. (1998) (503)
Diagnosis and Drug Treatment of Psychiatric Disorders (1969) (489)
Anxiety-new research and changing concepts (1984) (432)
Ventilatory physiology of patients with panic disorder. (1988) (351)
Response to hyperventilation in a group of patients with panic disorder. (1984) (339)
Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. (1976) (321)
Antidepressant specificity in atypical depression. (1988) (316)
Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. (1983) (315)
Diagnosis and drug treatment of psychiatric disorders : adults and children (1980) (310)
Smoking and panic attacks: an epidemiologic investigation. (1999) (307)
PSYCHIATRIC REACTION PATTERNS TO IMIPRAMINE (1962) (300)
Resolved: mania is mistaken for ADHD in prepubertal children. (1998) (299)
Treatment of agoraphobia with group exposure in vivo and imipramine. (1980) (291)
Barriers to the treatment of social anxiety. (2000) (271)
Generalized social phobia. Reliability and validity. (1995) (268)
Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. (1992) (263)
Accuracy of adult recall of childhood attention deficit hyperactivity disorder. (2002) (245)
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. (2000) (240)
Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects. (2015) (239)
Importance of psychiatric diagnosis in prediction of clinical drug effects. (1967) (238)
Premorbid asocial adjustment and prognosis in schizophrenia. (1969) (236)
Delineation of two drug-responsive anxiety syndromes (1964) (233)
Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse. (1972) (232)
Controlled Imipramine Treatment of School Phobia (1971) (227)
Phenelzine v imipramine in atypical depression. A preliminary report. (1984) (225)
Relationship between cingulo-insular functional connectivity and autistic traits in neurotypical adults. (2009) (223)
Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. (1993) (223)
Monoamine oxidase inhibitors. A review of antidepressant effectiveness. (1979) (222)
Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder. (1994) (220)
Measurement of lactate-induced panic and anxiety (1987) (219)
Akinesia: A Poorly Recognized Drug-Induced Extrapyramidal Behavioral Disorder (1975) (219)
Behavior therapy, supportive psychotherapy, imipramine, and phobias. (1978) (217)
An Open Trial of Fluoxetine in the Treatment of Panic Attacks (1987) (216)
Specificity in familial aggregation of phobic disorders. (1995) (213)
Cognitive‐behavioral group therapy versus phenelzine in social phobia: Long term outcome (1999) (204)
A direct interview family study of social phobia. (1993) (184)
Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. (2010) (176)
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. (1988) (174)
AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. (2004) (174)
Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. (1992) (171)
Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results. (1976) (169)
Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year. (1977) (165)
Discontinuation of alprazolam treatment in panic patients. (1987) (158)
Divalproex treatment of disruptive adolescents: a report of 10 cases. (1997) (158)
Anxiety reconceptualized. (1980) (153)
Columbia Atypical Depression (1993) (150)
The Prevention of Depression and Anxiety (1999) (150)
Validation of a classroom observation code for hyperactive children. (1977) (148)
Methylphenidate and growth in hyperactive children. A controlled withdrawal study. (1988) (147)
Treatment of body-dysmorphic disorder with serotonin reuptake blockers. (1989) (147)
Reliability of anxiety assessment. I. Diagnostic agreement. (1989) (146)
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. (1990) (144)
Relationship between separation anxiety and panic and agoraphobic disorders. (1984) (142)
Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder (2004) (141)
Decomposing Intra-Subject Variability in Children with Attention-Deficit/Hyperactivity Disorder (2008) (141)
Metabolism of (‐) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit (1982) (140)
Lithium carbonate in emotionally unstable character disorder. (1972) (139)
Diagnostic and substance specificity of carbon-dioxide-induced panic. (1993) (136)
Are there differences between women's and men's antidepressant responses? (2002) (135)
Childhood separation anxiety disorder in patients with adult anxiety disorders. (1994) (130)
Fluoxetine in panic disorder. (1990) (129)
Gender differences in panic disorder: findings from the National Comorbidity Survey. (2002) (125)
Results of a genome-wide genetic screen for panic disorder. (1998) (125)
The clinical measurement of depressive disorders. (1987) (125)
SCHOOL PHOBIA: DIAGNOSTIC CONSIDERATIONS IN THE LIGHT OF IMIPRAMINE EFFECTS (1973) (123)
Differential carbon dioxide sensitivity in childhood anxiety disorders and nonill comparison group. (2000) (123)
Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22 (2000) (122)
Reading-disabled hyperactive children: A distinct subgroup of Attention Deficit Disorder with Hyperactivity? (1984) (121)
Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder (1991) (121)
Validity of clinical trials of antidepressants. (2000) (120)
Specificity of lactate infusions in social phobia versus panic disorders. (1985) (119)
Treatment of phobias. II. Behavior therapy and supportive psychotherapy: are there any specific ingredients? (1983) (118)
Panic, suffocation false alarms, separation anxiety and endogenous opioids (2008) (117)
Critical Issues in Psychiatric Diagnosis (1978) (117)
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. (1989) (114)
Chronological milestones to guide drug change. When should clinicians switch antidepressants? (1996) (114)
Relative efficacy of methylphenidate and behavior modification in hyperkinetic children: An interim report (1976) (112)
Classroom observation code for hyperactive children: a replication of validity. (1980) (109)
How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine (1986) (106)
A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. (2000) (106)
Blockade by imipramine or desipramine of panic induced by sodium lactate. (1981) (105)
CO2 challenge of patients with panic disorder. (1987) (104)
Tardive dyskinesia: are first signs reversible? (1977) (103)
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia (1998) (103)
Familial transmission of simple phobias and fears. A preliminary report. (1990) (103)
Withdrawal symptoms following dicontinuation of imipramine therapy. (1961) (102)
Imipramine in the treatment of social phobia. (1998) (102)
Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness. (1983) (102)
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design. (1991) (100)
Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. (1998) (100)
Interrelationship of hysteroid dysphoria and borderline personality disorder. (1981) (98)
A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. (1993) (97)
Effects of informant mental disorder on psychiatric family history data. (1994) (96)
Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal. (1978) (94)
When should a trial of fluoxetine for major depression be declared failed? (2003) (94)
Cortisol and sodium lactate-induced panic. (1989) (94)
Preventing hung juries about therapy studies. (1996) (93)
Imipramine treatment of cocaine abuse: possible boundaries of efficacy. (1995) (92)
Pituitary adrenocortical unresponsiveness in lactate-induced panic (1987) (90)
Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates. (1998) (90)
Anxiety and congenital central hypoventilation syndrome. (1994) (89)
Methylphenidate effects in learning disabilities. Psychometric changes. (1976) (88)
Social functioning in chronic depression: Effect of 6 weeks of antidepressant treatment (1988) (88)
Panic disorder and agoraphobia: hypothesis hothouse. (1996) (87)
Flawed meta-analyses comparing psychotherapy with pharmacotherapy. (2000) (87)
Possible mechanisms for lactate's induction of panic. (1986) (86)
Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. (1966) (85)
Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment? (1996) (85)
Ventilatory physiology of children and adolescents with anxiety disorders. (1998) (83)
Effect of Acute ß-Adrenergic Blockade on Lactate-Induced Panic (1983) (83)
Reanalysis of The National Institute of Mental Health Treatment of Depression Collaborative Research Program General Effectiveness Report (1993) (81)
The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children (2006) (80)
Effect of Antipanic Treatment on Response to Carbon Dioxide (1997) (79)
Panic and avoidance in agoraphobia. Application of path analysis to treatment studies. (1987) (78)
A Third-Pass Genome Scan in Panic Disorder: Evidence for Multiple Susceptibility Loci (2006) (77)
Studying the Clinician: Judgment Research and Psychological Assessment (1999) (75)
Children with reading disorders--II. Effects of methylphenidate in combination with reading remediation. (1983) (75)
Serotonin related functions in panic-anxiety: a critical overview. (1992) (74)
Treatment of Social Phobia with Atenolol (1985) (74)
Emetophobia: Preliminary results of an internet survey (2001) (73)
Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. (1997) (73)
Very High Dosage vs Standard Dosage Fluphenazine in Schizophrenia: Frederic Quitkin, MD; Arthur Rifkin, MD; Donald F. Klein, MD (1975) (73)
Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. (2010) (72)
Respiratory variability in panic disorder (2001) (71)
Panic induced by carbon dioxide inhalation and lack of hypothalamic–pituitary–adrenal axis activation (1999) (71)
Fluoxetine for hypochondriacal patients without major depression. (1993) (70)
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. (2010) (70)
Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. (1999) (70)
Testing the suffocation false alarm theory of panic disorder. (1994) (70)
Ambulatory monitoring of respiration in anxiety. (1996) (69)
Noradrenergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine responses to clonidine and comparison to healthy controls (1991) (69)
Predictive value of symptoms of atypical depression for differential drug treatment outcome. (1992) (68)
Effects of naloxone on patients with panic attacks. (1984) (67)
Specificity of panic response to CO(2) inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder. (2001) (67)
Whither Research Domain Criteria (RDoC)?: The Good, the Bad, and the Ugly. (2015) (67)
Drug abuse in a young psychiatric population. (1970) (67)
Heterogeneity of clinical response during placebo treatment. (1991) (67)
Psychiatric reaction patterns to imipramine. (2008) (67)
Delineating the boundaries of social phobia: Its relationship to panic disorder and agoraphobia (1990) (67)
Preliminary look at the effects of pregnancy on the course of panic disorder. (1994) (66)
Comprehensive Handbook of Psychopathology, 3rd ed. (2002) (64)
Alprazolam in the treatment of panic disorders. (1986) (63)
Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. (1988) (62)
A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. (1989) (62)
Panic attacks during placebo procedures in the laboratory. Physiology and symptomatology. (1993) (61)
Treatment of panic disorder with imipramine alone. (1984) (61)
Two behavioral syndromes in young adults related to possible minimal brain dysfunction. (1969) (60)
Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. (1995) (60)
Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. (1998) (60)
Blood gas changes and hypophosphatemia in lactate-induced panic. (1986) (60)
Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients. (1973) (60)
Lactate infusions in obsessive-compulsive disorder. (1985) (59)
Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions. (2005) (59)
Treatment of Depersonalization with Serotonin: Reuptake Blockers (1990) (57)
Psychiatric diagnosis in cocaine abuse (1989) (57)
The loss of serendipity in psychopharmacology. (2008) (57)
Psychopharmacological treatment of social phobia. (1985) (56)
Psychiatric manifestations of Lyme borreliosis. (1993) (56)
Idiopathic cardiomyopathy and panic disorder: clinical association in cardiac transplant candidates. (1987) (56)
Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment. (1990) (56)
Evaluation methodology. (1977) (56)
Computed tomography and neurological soft signs in obsessive-compulsive disorder (1993) (56)
Atypical depression: current status and relevance to melancholia (2007) (55)
Extrapyramidal side effects with lithium treatment. (1978) (55)
Imipramine response in deluded depressive patients. (1978) (55)
A three-year posthospital follow-up of adolescent and adult schizophrenics. (1968) (54)
PREGNANCY AND BIRTH COMPLICATIONS IN PSYCHIATRIC PATIENTS: A COMPARISON OF SCHIZOPHRENIC AND PERSONALITY DISORDER PATIENTS WITH THEIR SIBLINGS (1973) (54)
Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics. (1978) (54)
Relationship between separation anxiety disorder, parental panic disorder, and atopic disorders in children: a controlled high-risk study. (2002) (53)
The tyramine challenge test as a marker for melancholia. (1984) (53)
Low frequency fluctuations reveal integrated and segregated processing among the cerebral hemispheres (2011) (52)
Subtypes of Ataques de Nervios: The Influence of Coexisting Psychiatric Diagnosis (1998) (51)
A model of panic and agoraphobic development (1987) (51)
Different types of placebo response in patients receiving antidepressants. (1991) (51)
Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. (1988) (51)
Anxiety attacks with subsequent agoraphobia. (1969) (50)
No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder (2001) (50)
Panic disorder and social phobia: effects of comorbidity on familial transmission. (1996) (49)
Withdrawal reaction to diazepam. (1976) (49)
Carbon Dioxide Hypersensitivity in Separation-Anxious Offspring of Parents with Panic Disorder (2010) (49)
Are Behavioral and Psychometric Changes Related in Methylphenidate-Treated, Hyperactive Children? (1975) (48)
The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective. (1984) (48)
Tidal volume of respiration and "sighing" as indicators of breathing irregularities in panic disorder patients. (1996) (48)
Epinephrine infusions in patients with social phobia. (1988) (47)
A pilot study of noradrenergic and HPA axis functioning in PTSD vs. panic disorder (2002) (47)
Reliability of anxiety assessment. II. Symptom agreement. (1989) (47)
PERCEPTUAL EVIDENCE OF CNS DYSFUNCTION IN SCHIZOPHRENIA. (1964) (47)
Further Evidence That a Placebo Response to Antidepressants Can Be Identified (1993) (46)
THE PREDICTION OF REHOSPITALIZATION: THE RELATIONSHIP BETWEEN AGE OF FIRST PSYCHIATRIC TREATMENT CONTACT, MARITAL STATUS AND PREMORBID ASOCIAL ADJUSTMENT (1971) (46)
DSM-IV Depression with Atypical Features: Is It Valid? (2009) (46)
Organic brain syndrome during lithium carbonate treatment. (1973) (45)
No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder (2000) (45)
The mitral valve prolapse—panic disorder connection. (1988) (45)
Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. (1978) (44)
Rebreathing tests in panic disorder (1995) (44)
Analogical reasoning and postoperative outcome. Predictions for patients scheduled for open heart surgery. (1976) (43)
The Treatment of Anxiety Disorders: Clinician's Guide and Patient Manuals (1998) (43)
Clinical trials design lessons from the CATIE study. (2009) (43)
Prophylaxis of affective disorders. Current status of knowledge. (1976) (42)
Low dose fluphenazine decanoate in maintenance treatment of schizophrenia (1979) (42)
Hypersensitivity to carbon dioxide in panic disorder. (1989) (42)
Normalization of venous pH, pCO2, and bicarbonate levels after blockade of panic attacks (1985) (40)
Panic disorder and suicide attempts (1992) (40)
Listening to meta-analysis but hearing bias. (1998) (40)
Anxiety responses to CO2 inhalation in subjects at high-risk for panic disorder. (2006) (39)
Sodium D-lactate infusion of panic disorder patients. (1990) (39)
Occult thyroid dysfunction in patients with refractory depression. (1988) (39)
Placebo run-in period in studies of depressive disorders (1998) (39)
Arterial blood gas changes in panic disorder and lactate- induced panic (1989) (39)
Beyond Significance Testing: Reforming Data Analysis Methods in Behavioral Research (2005) (39)
Baseline Matters: The Importance of Covariation for Baseline Severity in the Analysis of Clinical Trials (2011) (38)
Problems in the Diagnosis of Minimal Brain Dysfunction and the Hyperkinetic Syndrome (1975) (38)
Dr. Quitkin and Associates Reply (1979) (38)
Analogy tests and psychopathology at follow-up after open heart surgery. (1976) (37)
Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients. (2005) (37)
Behavioral Reaction Patterns with Phenothiazine (1962) (36)
Harmful dysfunction, disorder, disease, illness, and evolution. (1999) (36)
On the orthomolecular environment of the mind: orthomolecular theory. (2015) (36)
Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder (2007) (36)
Loss of drug effects during continuation therapy. (1993) (36)
Vulnerability to sodium lactate in panic disorder patients given cognitive-behavioral therapy. (1991) (35)
Discordance between the SCL-90 and therapists' psychopathology ratings. (1983) (35)
Nutrients and toxins of plants in Amboseli, Kenya (1987) (35)
The substantive effect of variations in panic measurement and agoraphobia definition (1989) (35)
Comparison of the clinical effectiveness of "short" versus "long" stay psychiatric hospitalization. III. Further results of a 3-year posthospital follow-up. (1977) (35)
Psychiatric diagnosis and a typology of clinical drug effects (2004) (35)
Lactate provocation of panic attacks in depressed outpatients (1988) (35)
Acute panic inventory symptoms during CO2 inhalation and room‐air hyperventilation among panic disorder patients and normal controls (2001) (35)
Child panic revisited. (1992) (34)
Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss (2010) (33)
Dopaminergic sensitivity and cocaine abuse: Response to apomorphine (1990) (33)
A Method to Quantify Rater Bias in Antidepressant Trials (2000) (33)
Improving clinical trials: American Society of Clinical Psychopharmacology recommendations. (2002) (33)
Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. (1990) (32)
The pharmacotherapy of minor depression. (1992) (32)
Hyperventilation occurs during lactate-induced panic (1988) (32)
The identification and validation of distinct depressive syndromes in a population-based sample of female twins. (1997) (32)
Lifelong opioidergic vulnerability through early life separation: A recent extension of the false suffocation alarm theory of panic disorder (2014) (32)
Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. (2000) (32)
Control groups in pharmacotherapy and psychotherapy evaluations. (1997) (32)
Neurologic Soft Signs in Obsessive-Compulsive Disorder-Reply (1991) (32)
Hysteroid dysphoria. (1982) (31)
Anxiety sensitivity among children of parents with anxiety disorders: a controlled high-risk study. (2002) (31)
Exercise tolerance in panic disorder patients (1992) (31)
Lactate vulnerability of remitted panic patients (1985) (31)
Lithium-induced folliculitis. (1973) (30)
Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD (1993) (30)
Further evidence that a placebo response to antidepressants can be identified. (1993) (30)
Effect of sodium lactate on patients with panic disorder and mitral valve prolapse. (1981) (30)
Clinical Pharmacological Management of Hyperkinetic Children (1975) (30)
Very high dosage fluphenazine for nonchronic treatment-refractory patients. (1971) (30)
Platonic true scores and error in psychiatric rating scales. (1967) (30)
MARITAL STATUS AS A PROGNOSTIC INDICATOR IN SCHIZOPHRENIA (1968) (30)
The definition and psychopharmacology of spontaneous panic and phobia. (1989) (29)
Anxiety reconceptualized. Gleaning from pharmacological dissection--early experience with imipramine and anxiety. (1987) (29)
Psychosocial treatment of schizophrenia, or psychosocial help for people with schizophrenia? (1980) (29)
Sexual Aversion, Sexual Phobias and Panic Disorder (1987) (29)
Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data. (1977) (29)
Symptoms Essential to the Experience of Sodium Lactate-Induced Panic (1996) (29)
Mitral valve prolapse and panic disorders effect of imipramine (1981) (28)
Birth Weight and Length in Schizophrenics Personality Disorders and Their Siblings (1971) (28)
Possible respiratory abnormalities in panic disorder. (1986) (28)
Noradrenergic function in panic disorder effects of intravenous clonidine pretreatment on lactate induced panic (1992) (27)
Growth hormone response to dextroamphetamine in depressed patients and normal subjects. (1982) (27)
Electroencephalographic correlates of suicide ideation and attempts. (1972) (27)
Phenelzine versus imipramine in atypical depression: a preliminary report (1985) (26)
Plasma Anti-Serotonin and Serotonin Anti-Idiotypic Antibodies Are Elevated in Panic Disorder (1999) (26)
Specific phobia 10–16 years after treatment (1999) (26)
Prevalence of mitral valve prolapse in panic disorder: effect of echocardiographic criteria. (1986) (26)
Efficacy of desipramine in endogenomorphically depressed patients. (1980) (25)
Covert drug abuse among voluntary hospitalized psychiatric patients. (1971) (25)
Organizational requirements for effective clinical effectiveness studies. (1999) (25)
Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders (1965) (25)
Thyroid dysfunction in phobic patients. (1984) (24)
Clinical psychopharmacologic practice. The need for developing a research base. (1993) (24)
Cardiac left ventricular hypertrophy and chamber dilatation in panic disorder patients: Implications for idiopathic dilated cardiomyopathy (1990) (24)
Understanding Depression: A Complete Guide to Its Diagnosis and Treatment (1993) (24)
Anxiety and panic attacks in the medically ill. (1981) (24)
Instructional set does not alter outcome of respiratory challenges in panic disorder (1995) (24)
Imipramine treatment of school phobia. (1969) (24)
A pilot follow-up study of childhood soft signs and the development of adult psychopathology. (1991) (24)
EKG effects of imipramine treatment in children. (1978) (23)
A reappraisal of atypical depression. (2003) (23)
An objective marker of lactate-induced panic (1987) (22)
Consistencies between recalled panic and lactate-induced panic. (1994) (22)
NIMH collaborative research on treatment of depression. (1990) (22)
Hypoglycemia and panic attacks. (1984) (21)
Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison [proceedings]. (1981) (21)
Effect of imipramine on prolapsed mitral valves of patients with panic disorder. (1981) (21)
Clomipramine treatment of panic disorder: pros and cons. (1997) (21)
Panic and phobic anxiety: phenotypes, endophenotypes, and genotypes. (1998) (21)
Peer Commentaries on Spitzer (2003) (2003) (21)
Platelet monoamine oxidase activity in patients with panic disorder (1985) (20)
Medication in the treatment of panic attacks and phobic states. (1982) (20)
Very high dosage vs standard dosage fluphenazine in schizophrenia. A double-blind study of nonchronic treatment-refractory patients. (1975) (20)
Drug therapy strategies for treatment-resistant depression. (1988) (19)
VISUAL HALLUCINATIONS WITH IMIPRAMINE. (1965) (19)
Emotionally unstable character disorder--a follow-up study. I. Description of patients and outcome. (1972) (19)
A Typological Model for Estimation of Drug and Placebo Effects in Depression (2002) (19)
The safety of a single daily dose schedule for imipramine. (1971) (18)
Lithium in Other Psychiatric Disorders (1973) (18)
Follow-up of treatment failure: psychosis and character disorder. (1967) (18)
Prolactin and sodium lactate-induced panic (1989) (18)
Familial transmission of panic disorder: effect of major depression comorbidity. (1994) (18)
Bromocriptine treatment of relapses seen during selective serotonin re-uptake inhibitor treatment of depression. (1995) (18)
A comparison of phobic subtypes within panic disorder (1991) (18)
Imipramine side effects in children (1974) (18)
What conditions are necessary to assess antidepressant efficacy? (2000) (17)
Body-dysmorphic disorder (I: Reply) (1990) (17)
Social competence and posthospital outcome. (1968) (17)
B-Mitten EEG pattern and process and reactive schizophrenia. A replication. (1972) (16)
Evaluating outcome criteria used in methadone maintenance programs. (1976) (16)
Behavioral effects of diphenylhydantoin in severe psychiatric disorders. (1967) (16)
"Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder? (2003) (16)
Agitated depression, alprazolam, and panic anxiety. (1986) (16)
The effect of lithium on thyroid functioning: a controlled study. (1974) (15)
An extension of the acquaintanceship procedure in family studies of mental disorder. (1992) (15)
Obsessive compulsive disorder, depression, and fluoxetine. (1991) (15)
Differential diagnosis and treatment of panic attacks and phobic states. (1981) (15)
The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics. (1979) (15)
Clinical effectiveness of "short" vs "long" psychiatric hospitalization. I. Inpatient results. (1976) (15)
A measure of severity of multi-drug use among psychiatric patients. (1971) (15)
Fenfluramine, cortisol, and anxiety (1990) (15)
The drug treatment of depression. (1970) (14)
Comparison of medical and psychological tests. (2002) (14)
The lactate infusion model. (1985) (14)
An inverse correlation between serum levels of desmethylimipramine and melatonin-like immunoreactivity in DMI-responsive depressives (1981) (14)
An ethical dilemma in child psychiatry (1995) (14)
Panic disorder with agoraphobia (1993) (14)
Comparison of the clinical effectiveness of "short" versus "long" stay psychiatric hospitalization. II. Results of a 3-year posthospital follow-up. (1977) (14)
A comparison of successive screening and discriminant function techniques in medical taxonomy. (1969) (14)
Improving detection of adverse effects of marketed drugs. (2007) (14)
Comparison of short-term treatment regimens in phobic patients: a preliminary report. (1976) (14)
Antianxiety Agents: Drugs in Psychiatry, vol. 2 (1986) (14)
Schizophrenia, panic anxiety, and alprazolam. (1987) (14)
Pharmacotherapy in the Treatment of Posttraumatic Stress Disorder (1995) (13)
Prediction of psychopharmacologic effect in man: development and validation of a computerized diagnostic decision tree. (1969) (13)
Investigation of polymorphisms in the CREM gene in panic disorder (2004) (13)
Age of onset of drug abuse in psychiatric inpatients. (1972) (13)
Comparison of the Clinical Effectiveness of “Short” Versus “Long” Stay Psychiatric Hospitalization IV. Predictors of Differential Benefit (1979) (13)
Psychopharmacologic treatment of panic disorder. (1984) (13)
Historical aspects of anxiety (2002) (13)
Sodium lactate infusion, panic attacks, and ionized calcium. (1984) (13)
The utility of the super-normal control group in psychiatric genetics (1993) (13)
Hemodynamic response to respiratory challenges in panic disorder. (1998) (13)
A survey of psychotropic medications not available in the United States. (1991) (13)
The reliability of a decision tree technique applied to psychiatric diagnosis. (1972) (13)
Mind, Mood, and Medicine: A Guide to the New Biopsychiatry (1981) (13)
Do panic disorder patients indiscriminately endorse somatic complaints? (1989) (12)
Emotionally unstable character disorder--a follow-up study. II. Prediction of outcome. (1972) (12)
A comparison of treated and untreated simple phobia. (1993) (12)
Central nervous system drug development, basic, and clinical research: thinking outside the box. (2011) (12)
A comparison of trimipramine and imipramine: a controlled study. (1980) (12)
Pregnancy and panic disorder. (1994) (12)
Posthospital adjustment of psychiatrically hospitalized drug users. (1974) (12)
School phobia: controlled imipramine treatment. (1971) (12)
Current psychotherapeutic drugs (1996) (12)
PREDICTION OF DRUG EFFECT IN PERSONALITY DISORDERS (1973) (12)
Improving the Pedagogy Associated With the Teaching of Psychopharmacology (2007) (11)
Effect of panic attacks on the treatment of atypical depressives. (1985) (11)
Chlorpromazine‐procyclidine and imipramine: Effects on thyroid function in psychiatric patients (1969) (11)
Prophylactic lithium with and without imipramine for bipolar I patients: a double-blind study [proceedings]. (1981) (11)
Social competence and posthospital outcome among schizophrenic and nonschizophrenic psychiatric patients. (1969) (11)
Response differences of spontaneous panic and fear. (2002) (11)
The Cause and Treatment of Agoraphobia-Reply (1988) (11)
Effects of intravenous diazepam pretreatment on lactate-induced panic (1995) (11)
Phenelzine and delusions of parasitosis: a case report. (1978) (10)
Can schizophrenia with premorbid asociality be genetically distinguished from the other forms of schizophrenia? (1980) (10)
Interaction between delta opioid receptors and benzodiazepines in CO2-induced respiratory responses in mice (2011) (10)
Treatment of acute schizophrenia with ultra-high-dose fluphenazine: a failure at shortening time on a crisis-intervention unit. (1975) (10)
Reflections on instituting a computerized psychosocial history in a clinical facility. (1977) (10)
Platonic true scores: further comment. (1969) (10)
Improvement of phase III psychotropic drug trials by intensive phase II work. (1991) (10)
Fourteen and six per second positive spikes in psychiatric patients and their sibs. (1969) (10)
SEVERE PAPILLEDEMA ASSOCIATED WITH DRUG THERAPY (1961) (10)
Prediction of drug effect by diagnostic decision tree. (1968) (10)
Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics. (1976) (10)
THE HOSPITALIZATION PRONENESS SCALE AS A PREDICTOR OF RESPONSE TO PHENOTHIAZINE TREATMENT (1968) (10)
EFFECTS OF CHLORPROMAZINE AND IMIPRAMINE ON SYSTOLIC BLOOD PRESSURE IN PSYCHIATRIC PATIENTS: RELATIONSHIPS TO AGE, DIAGNOSIS AND INITIAL BLOOD PRESSURE. (1964) (10)
Multiple item factors as change measures in psychopharmacology (1963) (9)
The B-Mitten EEG Pattern in Process and Reactive Schizophrenia and Affective States (1972) (9)
Siblings of Schizophrenic and: Psychopathology and Gender Concordance (1969) (9)
An Open-Label Pilot Study to Evaluate the Efficacy of Sildenafil Citrate in Middle-Aged Men With Late-Onset Dysthymia (2008) (9)
Psychopharmacologic validation of atypical depression. (1984) (9)
Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate. (1978) (9)
Withdrawal from diazepam. (1977) (9)
A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder (1993) (9)
Sodium lactate response and familial risk for panic disorder. (1995) (9)
Asthma and psychiatric illness. (2001) (9)
The effect of acetazolamide on ventilation in panic disorder patients. (1993) (8)
Effect of acute beta-adrenergic blockade on lactate-induced panic. (1983) (8)
Dealing With the Effects of Therapy Allegiances (2006) (8)
Imipramine as an adjunct to phenothiazine therapy. (1962) (8)
Classifying depression. (2001) (8)
In a rat model of panic, corticotropin responses to dorsal periaqueductal gray stimulation depend on physical exertion (2015) (8)
A comparison of analysis of covariance and the theta technique as applied to illustrative psychopharmacological data. (1979) (7)
Discussion of "methodological controversies in the treatment of panic disorder". (1996) (7)
How Should We Teach Psychopharmacology to Residents? (2001) (7)
Psychiatric case studies: treatment, drugs, and outcome (1972) (7)
Advancing DSM: Dilemmas in Psychiatric Diagnosis (2004) (7)
Mixed anxiety depression. For and against. (1993) (7)
Behavioral reaction patterns with phenothiazines. (1962) (7)
Prevention of degenerative disease: a controlled study of anticoagulant prophylaxis. (1961) (7)
Conflict of Interest, Journal Review, and Publication Policy (2008) (7)
A Single Daily Dose of a New Form of Amitriptyline in Depressive Illness (1972) (7)
Electroencephalographic correlates of oral contraceptive use in psychiatric patients. (1976) (7)
The utility of the panic disorder concept (2004) (7)
Analysis and display of psychopharmacological data. (1975) (6)
Response to Rothman and Michels on placebo-controlled clinical trials. (1995) (6)
Does panic disorder exist in childhood? (1990) (6)
Alcohol use disorders in relatives of patients with panic disorder. (2006) (6)
SEX DIFFERENCES IN THE RELATIONSHIP BETWEEN PREMORBID ASOCIALITY AND POSTHOSPITAL OUTCOME (1969) (6)
37. Ambulatory monitoring of respiration in panic disorder (1996) (6)
Psychotropic drug action. (1997) (6)
NEUROLOGIC SOFT SIGNS IN OBSESSIVE-COMPULSIVE DISORDER. AUTHOR'S REPLY (1991) (6)
Improved statistical analysis of moclobemide dose effects on panic disorder treatment (2010) (6)
A study of abrupt lithium withdrawal (1975) (6)
Antipanic drug effects during lactate infusion in lactate-refractory panic patients (1987) (6)
Hematologic alterations and CO2 hypersensitivity in male panic disorder patients and normal controls: Similarities to high‐altitude hypoxia and chronic lung disease (2001) (6)
Comments on Psychiatric Education (2005) (5)
Group Matching: Is This a Research Technique to Be Avoided? (1988) (5)
Efficacy of desipramine in mildly depressed patients: a double-blind, placebo-controlled trial [proceedings]. (1981) (5)
PREMORBID ASOCIAL ADJUSTMENT AND OUTCOME IN SCHIZOPHRENIA (1978) (5)
Recent developments in the understanding and pharmacotherapy of panic attacks. (1986) (5)
The Agoraphobic Syndrome: Behavioural Approaches to Evaluation and Treatment (1984) (5)
Critiquing McNally's reply (1996) (5)
Antidepressants and Stimulants: Efficacy of desipramine in depressed outpatients, response according to Research Diagnostic Criteria diagnoses and severity of illness (1983) (5)
Accurate meta-analytical assessment of "true antidepressant effects" needed. (2005) (5)
Klein's Suffocation Theory of Panic-Reply (1994) (5)
Mepazine (pacatal): Clinical trial with placebo control and psychological study (1960) (5)
Response of panic patients and normal controls to lactate infusions (1986) (5)
Industry withdrawal from psychiatric medication development. (2014) (5)
Effects of imipramine and phenelzine on plasma PEA levels (1988) (5)
Reply to Kirsch's Rejoinder Regarding Antidepressant Meta-Analysis (1998) (5)
Scapegoating in hospitalized adolescents. A behavioral phenomenon associated with schizophrenia with premorbid asociality. (1973) (4)
A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics. (1977) (4)
Women and scientific thought (1992) (4)
Childhood Separation Anxiety and Adult Agoraphobia (2019) (4)
Drug Treatment of Separation Anxious and Depressive Illness in Children (1978) (4)
Methoxy-catecholamine excretion and the mecholyl test. (1965) (4)
What should the package insert be? (1974) (4)
A slippery slope. (1980) (4)
Social values and drug use among psychiatric patients. (1972) (4)
Research report Anxiety responses to CO 2 inhalation in subjects at high-risk for panic disorder (2006) (4)
The significance of panic in general medicine. (1998) (4)
A psychotherapeutic context for clinical trials is promising, but manualization is not. (1997) (4)
Constancy and Change in Human Development (1981) (4)
Smoking and Panic Attacks (2015) (4)
Order‐Preserving Dimension Reduction Procedure for the Dominance of Two Mean Curves with Application to Tidal Volume Curves (2008) (4)
Evaluation of psychological therapies : psychotherapies, behavior therapies, drug therapies, and their interactions : proceedings of the sixty-fourth annual meeting of the American Psychopathological Association (1977) (4)
Psychopharmacological Practice and Health Reform (1995) (4)
Panic disorder (multiple letters) [8] (1999) (3)
Relationship between electroencephalographic and sociometric variables among psychiatric patients. (1970) (3)
Conceptual Antecedents of the Anxiety Disorders (2007) (3)
Problems with and promises of monoamine oxidase inhibitors. (1986) (3)
Low Dose Fluphenazine Decanoate in Treatment of Schizophrenia (1979) (3)
Psychoactive Drugs and Social Judgment: Theory and Research (1976) (3)
Response to critique of suffocation alarm theory (1994) (3)
Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings]. (1977) (3)
Acetazolamide as a control for CO2-induced panic. (1990) (3)
Effects of psychotropic drugs on long-term adjustment (1964) (3)
FDA post-marketing safety decisions. (2006) (3)
Some Physiological, Biochemical and Psychological Concomitants of Lactate-Induced Panic (1982) (3)
New-Onset Psychosis and Emergence of Suicidal Ideation With Aripiprazole (2010) (3)
Automating the psychiatric case study. (1970) (3)
Identified Placebo Treatment? (1994) (3)
Genes and environment: Nosology and psychiatry (2009) (3)
Scientific fraud and misconduct. (1991) (3)
Commentary by a clinical scientist in psychopharmacological research. (2007) (3)
Insulin levels during lactate infusion. (1984) (3)
Psychiatric diagnosis, activation, and radioactive iodine uptake. (1968) (3)
Chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. (1966) (3)
Panic developments. (2012) (3)
Siblings of schizophrenic and nonschizophrenic psychiatric patients. Psychopathology and gender concordance. (1969) (3)
Panic Attacks in Phobia Treatment Studies-Reply (1983) (2)
Pseudopregnancy. Treatment of periodic psychiatric illness: a pilot study. (1970) (2)
Diagnostic implications of the B-mitten EEG pattern: relationship to primary and secondary affective dysregulation. (1976) (2)
Psychopharmacological dissection of nonendogenous depression. (1984) (2)
Phobia Study Criteria-Reply (1983) (2)
Letter: On prophylaxis in unipolar affective disorder. (1976) (2)
Psychiatric evaluation services to court referred drug users. (1975) (2)
14 AND 6 PER SECOND POSITIVE SPIKING: Developmental and Clinical Correlates in Psychiatric Patients and Their Siblings (1974) (2)
TAKING CHRONIC FATIGUE SYNDROME SERIOUSLY. REPLY (1992) (2)
Imipramine, behavior therapy, and phobia. (1975) (2)
Correlational versus experimental studies (1992) (2)
Repeated observations of yawning, clitoral engorgement, and orgasm associated with fluoxetine administration. (1989) (2)
SSRIs in Children and Suicide (2004) (2)
Treatment of Panic Disorder, Agoraphobia, and Social Phobia (1995) (2)
The EEG qualities in a group of young adult hospitalized psychiatric patients. (1965) (2)
Indications for specific treatments of depressions. (1975) (2)
Application of Computer Techniques to Medical Data (1965) (2)
Lexicon of Psychiatry, Neurology and Neurosciences (1995) (2)
Difficulties in panic studies. (2013) (2)
Prodromal symptoms in agoraphobia and panic disorder. (1989) (2)
Psychobiology and psychopharmacology: issues in clinical research training. (1986) (2)
Psychotropic drug development: Challenge and promise (1990) (2)
233. Panic disorder is unlikely to be a homogeneous autosomal dominant disorder: Results of a genome-wide genetic screen (1996) (2)
Is prophylactic procyclidine necessary? (1977) (1)
RELATIONSHIPS OF THE MECHOLYL TEST, PREMORBID ASOCIAL FUNCTIONING, AND LONG TERM OUTCOME IN SCHIZOPHRENIA (1970) (1)
What's New in DSM-IV? (1995) (1)
Improving Scientific Publications and Public Trust by Data Access (2002) (1)
RDoC is adverse to scientific creativity (2016) (1)
Drug Therapy for Agoraphobia-Reply (1988) (1)
Promising medications not available in the United States (1994) (1)
Counterevidence from psychopharmacology, psychopathology, and psychobiology (1995) (1)
Children's Unestablished Rights (1981) (1)
Novel antidepressants: a clinical trial of mianserin [proceedings]. (1981) (1)
MANAGEMENT PROBLEMS AT HILLSIDE HOSPITAL 1960 AND 1963. (1964) (1)
Taking chronic fatigue syndrome seriously. (1992) (1)
Psychopharmacology: Special considerations (1982) (1)
A Subgroup of Depressives with Better Response to MAOI than to Tricyclic Antidepressants or Placebo (2018) (1)
Does imipramine worsen atypical depression? (1991) (1)
Possible effect of race on tricyclic plasma levels. (1978) (1)
Reply to Kocsis Letter (2010) (1)
Agoraphobia: Nature and Treatment (1982) (1)
Peer Review and Data Access (2002) (1)
A Quotation Problem (1979) (1)
Youthful Rebels - Diagnosis and Treatment. (1972) (1)
The Hillside Hospital treatment evaluation program. (1970) (1)
Monoamine oxidase inhibitors: A clinical colloquy (2014) (1)
American Psychiatric Press Review of Psychiatry, vol. 7 (1989) (1)
Promising psychopharmacologic medications not available in the USA (1995) (1)
CHILDREN WITH BIPOLAR DISORDER (1999) (1)
On Prophylaxis in Unipolar Affective Disorder (1976) (1)
Atypical signs of relapse in affective disorders. (1975) (1)
Supraventricular distinctions, tachycardia, and panic disorder. (1997) (1)
Clinical and biological aspects of depression in the elderly. (1980) (1)
Efficacious and Safe Psychotropics Not Available in the United States (1996) (1)
Understanding depression. (1995) (1)
Panic and Anxiety-Reply (1983) (1)
The pathophysiology of panic anxiety (1990) (1)
CHILDREN WITH BIPOLAR DISORDER. AUTHORS' REPLY (1999) (1)
Plasma-nortriptyline levels in depression. (1973) (1)
Letter: Pathophysiology of depressive syndromes. (1974) (1)
Further discussion of article on prodromal symptoms in panic disorder. (1990) (1)
Commentary on 'Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation?' (1991) (1)
Case 1. Assessment and treatment of phobic anxiety. (1979) (1)
Panic disorder (1999) (1)
SSRIs in children and suicide (letter) (2004) (1)
Imipramine and phobia [proceedings]. (1977) (0)
The Riggs Story (1962) (0)
The Biology of Anxiety (1983) (0)
Dr. Gorman and Associates Reply (1982) (0)
New article: backmatter.txt (1968) (0)
Respiration disorders in panic attacks. (1995) (0)
Early Development of Monoamine Oxidase Inhibitors (2014) (0)
A cybernetic theory of how psychotropic drugs work. (1986) (0)
The report by the Institute of Medicine and postmarketing surveillance. (1999) (0)
40. Smoking and panic disorder: an epidemiologic investigation (2000) (0)
The hospital treatment of the schizophrenic patient. Drugs and schizophrenia. (1969) (0)
Phobic about panics. (1987) (0)
What do you make of spontaneous panic attacks that, during the course of psychotherapy, are seen to be covering tremendous anger and serving a protective role? Would you classify them as endogenous or exogenous? Do they respond to medication? (1982) (0)
Misuse of the Symptom Checklist 90-Reply (1983) (0)
CO 2 Hypersensitivity in Separation Anxious Offspring of Parents with Panic Disorder (2013) (0)
Review of Panic: Psychological perspectives. (1990) (0)
"Concomitant use of methadone with other psychoactive drugs in the treatment of opiate addicts with other DSM-III diagnoses": Critique.: (471112004-001) (1983) (0)
Practical Management of the Side Effects of Psychotropic Drugs (2000) (0)
MULTIPLES : NO AMNESIA FOR CHILD ABUSE. AUTHORS' REPLY (1999) (0)
Can a year??s worth of psychotherapy in conjunction with diazepam use correct panic reactions, followed by treatment with minimal amounts of diazepam? (1982) (0)
Agoraphobia in the Light of Ego Psychology (1966) (0)
Interactive prediction of drug induced change (1974) (0)
Proceedings: Pharmacological response as a basis for syndrome identification. (1974) (0)
Modern Problems of Pharmacopsychiatry Series (1989) (0)
Schizophrenia and bipolar affective disorders: likenesses and differences. (1989) (0)
What’s Wrong With the Rorschach? Science Confronts the Controversial Inkblot Test (2004) (0)
Using (r) optically pure -tofisopam to treat and prevent anxiety disorders. (1999) (0)
Ritalin effects in children with learning disability (1974) (0)
Malady Causes Confusion (1982) (0)
Not a Panacea for Psychiatric Drugs. (1998) (0)
Do you ever combine a tricyclic antidepressant and a benzodiazepine to treat both the panic attacks and the anticipatory anxiety (1982) (0)
Comments on bulimia. (1990) (0)
Nottingham study of neurotic disorder. (1988) (0)
Phobia: Psychological and Pharmacological Treatment (1981) (0)
Psychological Development in Health and Disease (1963) (0)
The logic of ESP. (1970) (0)
Working at an unaccredited facility (1982) (0)
A reappraisal of atypical depression. Authors' reply (2003) (0)
Rheostat and cybernetic issues. (1988) (0)
Severe stage fright closely resembles a panic attack. Propranolol blocks the symptoms of stage fright but seldom helps patients with panic attacks. Any idea why (1982) (0)
Sustained Release Amitriptyline (Lentizol) in Depressive Illness (1973) (0)
Panic symptoms, cigarette smoking and drinking in adolescent female twins (2003) (0)
Age, Base Blood Pressure, Diagnosis, and Mecholyl Test Response (1966) (0)
Diagnosis and treatment prescription: Psychiatry's special value (1982) (0)
Biochemical Effects and Antidepressant Mechanisms of L-Deprenyl (1984) (0)
P-5-43 Breathing irregularities in panic disorder patients (1995) (0)
Panic, separation anxiety, and endorphins (1982) (0)
Should not panic disorders be classified as panic disorders, with or without agoraphobia, rather than agoraphobia, with or without panic attacks? (1982) (0)
Panic and agoraphobia's sequence of improvement during pharmacotherapy. (1992) (0)
If your speculations about the relationship of panic to Bowlby??s ideas are correct, (1) why is the dose of antidepressants different for panic and depression, and (2) why do panic disorders generally start in adult life? (1982) (0)
Breath of panic. (1998) (0)
Dr. Sheikh and Colleagues Reply (2002) (0)
Covert drug abuse. (1972) (0)
CME Monograph Tests (1984) (0)
Panic and Phobias 2: Treatments and Variables Affecting Course and Outcome (1990) (0)
CNS Effects of Mitral Commissurotomy (1964) (0)
Improving Medication and Legislation by Controlled Experimentation (1995) (0)
Intensive Design to Reinvigorate Psychiatric Drug Development (2015) (0)
Is conventional clinicaal wisdom wise? (1979) (0)
Unresolved issues in the treatment of agoraphobia with panic attacks. (1982) (0)
Proceedings: The relationship between behavioral and psychological test changes in hyperkinetic children. (1974) (0)
[No Title] (1998) (0)
Surviving Schizophrenia: A Family Manual—by E. Fuller Torrey, M.D.; Harper & Row, New York, 1983, 302 pages, $20 (1984) (0)
Current Obstacles to Drug Development (1997) (0)
Meeting of research committee Antwerp, 15 November, 1975 (1976) (0)
Can panic disorder patients become schizophrenic (1982) (0)
Etiological and Pathophysiological Inferences from the Pharmacological Treatment of Anxiety (2019) (0)
Heuristically Important Mood-Altering Drugs (1983) (0)
Do panic attacks occur at all ages? Can they occur for the first time after the age of 30? (1982) (0)
Theories must be tested. (1982) (0)
Decreased Tyramine Conjugation in Melancholia: A Trait Marker (1988) (0)
Commentary: the treatment of panic. (1998) (0)
Re: Clomipramine Treatment and Behaviour Therapy with Agoraphobic Women (1997) (0)
Pharmacotherapy of obsessive-compulsive disorder. (1990) (0)
Antidepressant quandaries. (1998) (0)
Paul Wender (2016) (0)
Reports on past meetings (1982) (0)
Boycott: Solution to Problems of Institutional Practice? (1981) (0)
Monoamine Oxidase Inhibitors: A Clinical Colloquy Edward H. Tobe, DO, DLFAPA; Jonathan W. Stewart, MD; (2014) (0)
Guidelines For Submissions (1983) (0)
Multiples: no amnesia for child abuse. (1999) (0)
Dr Frederic M Quitkin (2006) (0)
Behavioral and Neuroendocrine Responses to Oral m-Chlorophenylpiperazine and Fenfluramine in Patients and Healthy Volunteers (2016) (0)
EKG Effects of Imipramine Treatment in Children (1978) (0)
Apomorphine challenge in cocaine abusers (1989) (0)
Drug therapy as a means for identifying new psychopathological entities and progressively revising our nosology (1972) (0)
Comments on "Integrity and Misconduct in Research" (1996) (0)
Introduction (2007) (0)
PANIC DISORDER WITH AGORAPHOBIA. AUTHORS' REPLY (1993) (0)
A classification of patient-peer interaction. (1973) (0)
[No Title] (1994) (0)
A comparison of twin and sibling studies for a developmental theory of schizophrenia. (1970) (0)
Anxiety Disorders: Panic disorder and agoraphobia (2010) (0)
Some thoughts on the validity of the concept of panic disorder (1998) (0)
Imipramine and Agoraphobia (1983) (0)
Discussion of psychotropic effect of diphenylhydantoin (DPH). (1967) (0)
Fostering treatment advances. (2002) (0)
Single nucleotide polymorphism analysis in panic disorder candidate genes: Neuropeptide Y and the neuropeptide Y-Y1 receptor (2001) (0)
Treatment of Atypical Depression: Phenelzine, Imipramine, and Placebo (1986) (0)
Identifying adaptation by dysfunction (2002) (0)
Premorbid Asocial Adjustment Scale (2013) (0)
I have seen agoraphobics who, even with careful questioning, deny any history of panic attacks. How do you understand this? (1982) (0)
Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders (2002) (0)
and Their Siblings Birth Weight and Length in Schizophrenics Personality Disorders (2011) (0)
The Office of Research Integrity Biannual Report 1991–1992 (1995) (0)
Utilization of the psychiatric consultation service in a large city hospital. (1973) (0)
The Development of Nosological Concepts in Anxiety Disorders (1996) (0)
Contents, Vol. 17, Supplement 1, 1984 (1984) (0)
What is the rate of recurrence of panic attacks once you stop imipramine therapy (1982) (0)
CQY volume 35 Cover and Front matter (1968) (0)
Effect of Acute βAdrenergic Blockade on Lactate-lnduced Panic-Reply (1985) (0)
Letter: Pharmacotherapeutic investigation: time for change. (1975) (0)

This paper list is powered by the following services:

Other Resources About Donald F. Klein

en.wikipedia.org

What Schools Are Affiliated With Donald F. Klein?

Donald F. Klein is affiliated with the following schools: